Carolina Garcia Olmos Calil , MD

Silvia Hafliger, MD, is a board-certified psychiatrist trained in helping patients cope with medical illnesses involving organ transplants, cancer, HIV, diabetes, and heart disease. She treats depression, anxiety, insomnia, chronic pain, and substance abuse. She believes in empowering patients and families so they can collaborate effectively with their medical doctors and optimally manage self-care. Hafliger worked for 19 years at the Center for Liver Disease and Transplantation at Columbia University Medical Center in New York. She believes in collaborative and integrative care and started a psychosocial program for transplant patients that included transplant workshops, a post-transplant support group, and the Liver Connection Newsletter. Outside of work, she enjoys speed walking, knitting, and spending time with her dogs.

Meet Dr. Mira Milad an accomplished M.D. based in Houston TX. With a specialization in General Allopathic Medicine Dr. Milad is dedicated to providing top-notch medical care to her patients. As a Doctor of Medicine Dr. Milad holds expertise in a wide range of medical areas ensuring comprehensive healthcare solutions for those under her care. Her practice in Houston serves as a beacon of quality medical services in the community. Generated from this place's public information

Paul Schulz, M.D., is a professor of neurology at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). He received his combined BA-MD degrees from Boston University in 1984. He did a medical internship there, and moved to Baylor College of Medicine for his residency in Neurology. He stayed for a laboratory fellowship in cellular neurophysiology after which he became an assistant professor. Later, he was an associate professor of neurology, neuroscience, and translational biology and molecular medicine. Dr. Schulz was also the vice chair of education for neurology, the deputy chair of the Methodist neurology service, and directed the Cognitive Disorders Clinics at Baylor and the Houston Veterans Administration Hospital. Dementia Program In 2010, Dr. Schulz moved to Mischer Neuroscience Institute, where he sees patients who have cognitive, behavioral, or mood disorders. His group is investigating risk factors for dementia in order to understand why it develops, including both environmental and genetic factors. They use imaging, epidemiologic, and genetic approaches and have identified several risk factors. They are also investigating ways to diagnose dementia earlier, perhaps before symptoms develop, in order to determine whether interventions in the presymptomatic stage might delay or prevent the development of dementia. His group has early data suggesting that the treatment of some risk factors may reduce the probability of developing dementia. Dr. Schulz has received numerous awards and has been an invited speaker at major scientific meetings worldwide. He has been extensively published in the scientific literature and has been featured on television and radio shows.